TMTC Logo
|

Leukemia Treatment in India for Nigerian Patients: What Happens After Diagnosis?

What happens after a leukemia diagnosis? From treatment options and costs to seeking specialists, find answers to the questions Nigerian patients may have about leukemia treatment in India.
Published on 19 October 20267m
Dr Sukalpa Rathore

Medical content writer with dental expertise (BDS, MSc in F. Odont.), focused on cross-border healthcare.

patient in hospital talking to a female doctor
For Nigerian patients exploring leukemia treatment in India, understanding the diagnostic process, available treatment options and practical arrangements can make the next steps easier to navigate.
India offers specialist cancer care, including haematology services, chemotherapy, targeted therapy and stem cell transplantation at selected centres. The right approach depends on the type of leukemia, how quickly it is progressing, the patient's overall health and the results of specialised tests.
Here's what Nigerian patients should know about the journey from diagnosis to treatment planning.

What Happens After a Leukemia Diagnosis?

Leukemia is a cancer of the blood-forming tissues, including the bone marrow. It affects the production and function of blood cells. If blood tests suggest leukemia, further investigations are usually needed to confirm the diagnosis and identify the specific type.
These may include:
  • Complete blood count (CBC): Checks the levels of red blood cells, white blood cells and platelets.
  • Blood smear: Examines blood cells under a microscope for abnormalities.
  • Bone marrow aspiration and biopsy: Collects samples to assess abnormal cells in the bone marrow.
  • Flow cytometry: Helps identify the type of leukemia by examining specific markers on the cells.
  • Genetic and molecular tests: Look for chromosome changes or gene abnormalities that may influence treatment decisions.
  • Additional investigations: Kidney and liver function tests, infection screening and other assessments may be required before treatment.
Not every patient needs the same tests. A haematologist will recommend investigations based on the suspected diagnosis and clinical findings.
Once leukemia is confirmed, identifying its exact type and assessing its risk characteristics helps doctors determine the most appropriate treatment plan.

Understanding the Different Types of Leukemia

Leukemia is not a single disease. Treatment varies according to the type of blood cell affected and how quickly the disease progresses.

Acute lymphoblastic leukemia (ALL)

ALL develops rapidly and affects immature lymphoid cells. It is more common in children but can also occur in adults. Treatment often involves intensive chemotherapy, with targeted medicines or stem cell transplantation considered in selected cases.

Acute myeloid leukemia (AML)

AML develops rapidly and affects myeloid cells. Treatment may include intensive or lower-intensity chemotherapy, targeted medicines and, for selected patients, a stem cell transplant.

Chronic lymphocytic leukemia (CLL)

CLL usually progresses more slowly and affects lymphocytes. Some patients may be monitored without immediate treatment, while others may require targeted medicines or other drug therapies.

Chronic myeloid leukemia (CML)

CML affects myeloid cells and is often associated with a genetic change known as the Philadelphia chromosome. Many patients are treated with targeted medicines called tyrosine kinase inhibitors.
These are general descriptions. Two patients with the same type of leukemia may receive different treatment plans depending on their test results, age, general health and response to previous treatment.

What Are the Leukemia Treatment Options in India?

Indian cancer centres may offer several treatment approaches depending on the diagnosis and the patient's clinical needs.

1. Chemotherapy

Chemotherapy uses medicines to destroy cancer cells or stop them from multiplying. It is a major treatment option for several types of acute leukemia and may be given in phases over weeks or months.
Some patients require hospital admission during intensive treatment, while others may receive parts of their treatment as outpatients.

2. Targeted therapy

Targeted medicines act on specific genetic changes or proteins involved in cancer cell growth. They are particularly important in certain forms of CML and may also be used in selected cases of AML, ALL and CLL.
The choice of medicine depends on the leukemia subtype and relevant test results.

3. Immunotherapy

Some leukemia treatments use the immune system to recognise and attack cancer cells. Depending on the type of leukemia and previous treatment, options may include antibody-based therapies or specialised cellular treatments at selected centres.
These treatments are not suitable for every patient and may require specific eligibility assessments.

4. Stem cell or bone marrow transplantation

A stem cell transplant may be considered for selected patients, particularly those with certain high-risk leukemias or disease that has returned after treatment.
The procedure involves replacing the patient's blood-forming stem cells with healthy stem cells, often from a donor. Suitability depends on several factors, including disease status, general health and donor availability.
Patients should discuss the potential benefits, risks, recovery period and need for follow-up care with their specialist.

5. Supportive care

Supportive care is an important part of leukemia treatment. Depending on the patient's needs, it may include blood or platelet transfusions, infection management, medicines to manage side effects and nutritional support.
Your treating team should explain which treatments are recommended, why they are appropriate and whether alternatives are available.

How Much Does Leukemia Treatment Cost in India for Nigerians?

The leukemia treatment cost in India for Nigerians depends on the type of leukemia, the recommended treatment, the hospital, the length of admission and any additional medical requirements.
For patients who need a bone marrow transplant (BMT) or stem cell transplant, The Medical Travel Company helps coordinate more affordable treatment options in India than some alternative medical destinations.

BMT and Stem Cell Transplant Prices: India vs. Other Popular Destinations

TreatmentIndia (TMTC)Avg Cost in Another Destination
Bone Marrow Transplant (BMT)$24,000$88,000
Stem Cell Transplant$2,000$8,000
Based on these figures, treatment costs in India through TMTC are approximately 70% less than in any primary alternative destination.
Please note: These figures provide a starting point for comparison. Actual costs may vary depending on the patient's diagnosis, treatment requirements, hospital, donor-related expenses, length of stay and post-treatment care. Contact TMTC for the final treatment pricing.

Additional Costs to Consider for Nigerian Patients

For Nigerian patients travelling to India, the overall budget should also account for flights, accommodation, local transport, visa-related expenses, investigations, medicines and follow-up consultations.
Before making travel arrangements, request an itemised treatment estimate. Ask whether the quoted amount includes hospital admission, the transplant procedure, donor evaluation, medicines and recovery support, or whether any of these are charged separately.
A reliable estimate can only be prepared after a specialist reviews the patient's medical records and recommends an appropriate treatment plan.

What Medical Records Should Nigerian Patients Have?

Patients considering leukemia treatment in India may be able to arrange an initial review before travelling. Providing complete medical records can help the receiving specialist understand the diagnosis and identify any additional tests required.
Prepare the following, where available:
  • Blood test reports: Include complete blood counts and other relevant laboratory results.
  • Bone marrow reports: Share aspiration, biopsy and histopathology findings.
  • Flow cytometry results: These can help establish the leukemia subtype.
  • Genetic and molecular test reports: Include relevant chromosome studies and mutation testing.
  • Previous treatment records: List chemotherapy, targeted medicines, immunotherapy or transplantation, including dates and responses.
  • Imaging and other investigations: Include relevant reports requested by the treating team.
  • Current medication list: Mention prescribed medicines, allergies and other medical conditions.
  • Recent clinical summaries: Include discharge summaries and notes from the current haematologist or oncologist.
If some records are missing, contact the hospital or laboratory that conducted the tests to request copies.
An initial remote review can help with treatment planning, but it does not replace an in-person examination or further investigations when these are needed.

How TMTC Helps Nigerian Patients with Their Treatment in India

Travelling abroad for leukemia treatment involves more than choosing a hospital. The Medical Travel Company (TMTC) supports patients throughout their medical journey, including:
  • Specialist consultations: Coordinating medical record reviews and appointments with relevant specialists.
  • Hospital and treatment planning: Helping patients explore suitable hospitals, treatment options and cost estimates.
  • Travel and accommodation: Assisting with travel arrangements, local transport and accommodation.
  • Aftercare and recovery: Patients stay at TMTC's aftercare centre, equipped with 24/7 medical support and facilities to support recovery.
  • Follow-up care: Coordinating follow-up consultations with the medical team in India as well as your local doctor after you return home.
For leukemia patients, treatment schedules and travel requirements can vary considerably. TMTC helps coordinate arrangements based on each patient's needs, while treatment decisions and travel clearance remain with the treating medical team.
Before travelling, patients should discuss the proposed treatment schedule, expected length of stay and follow-up requirements with their specialist.

Taking the Next Step After a Leukemia Diagnosis

A leukemia diagnosis can feel overwhelming, but understanding the type of disease, the available treatments and the information doctors need can help patients and families prepare for the next steps.
For Nigerian patients exploring leukemia treatment in India, gathering medical records and requesting a specialist review can be a practical starting point.
Contact TMTC to explore treatment options in India and get support with planning your medical journey.

References

  • American Cancer Society. (n.d.). Leukemia.
    https://www.cancer.org/cancer/types/leukemia.html
  • National Cancer Institute. (n.d.). Leukemia-Patient version.
    https://www.cancer.gov/types/leukemia
  • National Cancer Institute. (2025, May 12). Acute lymphoblastic leukemia treatment (PDQ®) - Patient version.
    https://www.cancer.gov/types/leukemia/patient/adult-all-treatment-pdq
  • National Health Service. (n.d.). Treatment for acute lymphoblastic leukaemia.
    https://www.nhs.uk/conditions/acute-lymphoblastic-leukaemia/treatment/
  • National Health Service. (n.d.). Treatment for acute myeloid leukaemia.
    https://www.nhs.uk/conditions/acute-myeloid-leukaemia/treatment/
Leukemiacancer treatment in India

Ready to open the door to better health?

Decorative Underline Accent TMTC
Get in Touch Image TMTC